AmerisourceBergen’s acquisition of PharmaLex provides small and mid-sized biopharmas a new pathway to go to market independently and be successful.

As more prescription digital therapeutics receive approval, how can developers overcome existing barriers to maximize product success and patient acce

Biosimilars are on the brink of a big breakout the pharmaceutical and healthcare industries are prepared to maximize for better patient outcomes

As the cell and gene therapy market begins to emerge from infancy, the promise and hope of transformational new treatments face a raft of challenges.

As the pace of transformation in healthcare accelerates, how can digital solutions and innovation power access to the new wave of therapies?

The traditional pharmacy copay model is quickly shifting toward a patient focused format, forcing manufacturers to rethink their operational approach.

Corey Ford and Colleen Cummins sit down with Rebecca Willumson of Fierce Pharma to discuss the importance of patient affordability.

Read to learn more about some of the new innovative treatments by AmerisourceBergen available in the post-COVID world.

Learn more about the ways in which AmerisourceBergen has addressed the growing disparities in healthcare which were magnified by COVID-19.

Powering Global Access: Building a Reliable, Efficient Pharmaceutical Supply Chain